Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Gene Ther. 2013 Jan 10;20(4):450–459. doi: 10.1038/gt.2012.101

TABLE 3. GFP-positive cells in various brain and spinal cord regions.

Brain area NHP 201 NHP 202 NHP 203 NHP 204 NHP 205 NHP 206 Average Standard Deviation

1A caudate 63.0 56.5 52.7 51.7 50.5 50.6 54.2 4.9
1A putamen 54.7 52.2 51.2 50.5 50.3 50.1 51.5 1.8
1A thalamus 64.0 45.1 58.6 43.5 57.4 43.1 51.9 9.1
1B amygdala 58.7 58.9 49.9 54.1 48.0 53.0 53.8 4.5
1B lateral geniculate nucleus 41.7 59.7 41.1 59.2 41.0 59.1 50.3 9.9
1B lateral globus pallidus 62.7 50.8 55.2 65.4 45.8 58.8 56.5 7.4
2A corpus callusum 63.4 60.0 51.4 53.9 48.8 52.5 55.0 5.6
2A motor cortex 62.5 57.1 52.2 52.2 50.0 51.1 54.2 4.7
2B hippocampus 50.6 61.8 45.0 57.9 43.7 57.0 52.7 7.4
2B hypothalamus 56.3 69.7 44.7 60.9 42.3 59.0 55.5 10.3
2B thalamus 37.9 54.2 41.1 56.9 42.0 57.5 48.3 8.9
3B midbrain 40.6 65.4 38.3 63.0 37.8 62.5 51.3 13.6
5 cerebellum 65.5 65.9 49.8 56.9 46.7 54.9 56.6 7.9
5 pons 55.6 48.5 53.4 47.6 52.8 47.4 50.9 3.5
cervical spinal cord 45.1 26.2 63.2 29.3 68.3 30.0 43.7 18.4
thoracic spinal cord 25.0 38.0 39.7 48.9 44.8 52.2 41.4 9.7
lumbar spinal cord 74.6 52.6 58.6 100 37.0 73.0 66.0 21.7

GFP-positive cells were manually counted in 5-7 micron sections after anti-GFP IHC, and expressed as a percentage of the total number of cresyl violet-stained nuclei in the same section.